179 related articles for article (PubMed ID: 26540276)
1. New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
Chande N; Marshall JK; Seow CH; Sandborn WJ; Parker CE; Nelson S; Feagan BG
Inflamm Bowel Dis; 2015 Dec; 21(12):2948-57. PubMed ID: 26540276
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate: underused and ignored?
Herfarth HH; Long MD; Isaacs KL
Dig Dis; 2012; 30 Suppl 3(0 3):112-8. PubMed ID: 23295701
[TBL] [Abstract][Full Text] [Related]
3. Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients.
Ingrasciotta Y; Grova M; Crispino F; Isgrò V; Calapai F; Macaluso FS; Mattace-Raso F; Trifirò G; Orlando A
Minerva Gastroenterol (Torino); 2024 Mar; 70(1):98-108. PubMed ID: 34057333
[TBL] [Abstract][Full Text] [Related]
4. [A case of dual-targeted therapy for pediatric refractory inflammatory bowel disease].
Dai NN; Li J; Shi XY; Dong WX; Gao YJ; Zhu WW; Wang S; Li XY; Sun JB; Zhang J; Li ZL
Zhonghua Er Ke Za Zhi; 2024 Jun; 62(6):577-579. PubMed ID: 38763883
[TBL] [Abstract][Full Text] [Related]
5. Ileal Crohn's disease is best treated by surgery.
Farthing MJ
Gut; 2002 Jul; 51(1):13-4. PubMed ID: 12077084
[No Abstract] [Full Text] [Related]
6. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.
Gupta V; Rodrigues R; Nguyen D; Sauk J; Khalili H; Yajnik V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2016 Jan; 43(1):52-60. PubMed ID: 26541937
[TBL] [Abstract][Full Text] [Related]
8. Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease.
Minar P; Saeed SA; Afreen M; Kim MO; Denson LA
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):715-22. PubMed ID: 26551317
[TBL] [Abstract][Full Text] [Related]
9. Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.
Turner D; Koletzko S; Griffiths AM; Hyams J; Dubinsky M; de Ridder L; Escher J; Lionetti P; Cucchiara S; Lentze MJ; Koletzko B; van Rheenen P; Russell RK; Mack D; Veereman G; Vermeire S; Ruemmele F
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):183-7. PubMed ID: 26545204
[TBL] [Abstract][Full Text] [Related]
10. Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Parian A; Limketkai BN
Curr Pharm Des; 2016; 22(2):180-8. PubMed ID: 26561079
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis.
Brandse JF; Mathôt RA; van der Kleij D; Rispens T; Ashruf Y; Jansen JM; Rietdijk S; Löwenberg M; Ponsioen CY; Singh S; van den Brink GR; D'Haens GR
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):251-8.e1-2. PubMed ID: 26545802
[TBL] [Abstract][Full Text] [Related]
12. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.
Shah SC; Colombel JF; Sands BE; Narula N
Aliment Pharmacol Ther; 2016 Feb; 43(3):317-33. PubMed ID: 26607562
[TBL] [Abstract][Full Text] [Related]
13. Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies.
Fumery M; Duricova D; Gower-Rousseau C; Annese V; Peyrin-Biroulet L; Lakatos PL
Aliment Pharmacol Ther; 2016 Feb; 43(3):346-55. PubMed ID: 26582737
[TBL] [Abstract][Full Text] [Related]
14. Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.
Kuin S; Stolte SB; van den Brink GR; Ponsioen CY; Fockens P; D'Haens GR; Löwenberg M
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):222-5. PubMed ID: 26566062
[TBL] [Abstract][Full Text] [Related]
15. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
Harbord M; Annese V; Vavricka SR; Allez M; Barreiro-de Acosta M; Boberg KM; Burisch J; De Vos M; De Vries AM; Dick AD; Juillerat P; Karlsen TH; Koutroubakis I; Lakatos PL; Orchard T; Papay P; Raine T; Reinshagen M; Thaci D; Tilg H; Carbonnel F;
J Crohns Colitis; 2016 Mar; 10(3):239-54. PubMed ID: 26614685
[No Abstract] [Full Text] [Related]
16. Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies.
Van Deen WK; van der Meulen-de Jong AE; Parekh NK; Kane E; Zand A; DiNicola CA; Hall L; Inserra EK; Choi JM; Ha CY; Esrailian E; van Oijen MG; Hommes DW
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1742-1750.e7. PubMed ID: 26598228
[TBL] [Abstract][Full Text] [Related]
17. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
[TBL] [Abstract][Full Text] [Related]
18. A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.
Siegel CA; Horton H; Siegel LS; Thompson KD; Mackenzie T; Stewart SK; Rice PW; Stempak JM; Dezfoli S; Haritunians T; Levy A; Baek M; Milgrom R; Dulai PS; Targan SR; Silverberg MS; Dubinsky MC; McGovern DP
Aliment Pharmacol Ther; 2016 Jan; 43(2):262-71. PubMed ID: 26567467
[TBL] [Abstract][Full Text] [Related]
19. Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis.
Hussey M; Mc Garrigle R; Kennedy U; Holleran G; Kevans D; Ryan B; Breslin N; Mahmud N; McNamara D
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):217-21. PubMed ID: 26587866
[TBL] [Abstract][Full Text] [Related]
20. Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis.
Lee SY; Jamal MM; Nguyen ET; Bechtold ML; Nguyen DL
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):210-6. PubMed ID: 26545085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
